MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCER
- 6 February 1988
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 331 (8580) , 268-271
- https://doi.org/10.1016/s0140-6736(88)90351-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The clinical significance of pre-operative serum CA 125 in ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second‐look operations and their role in the detection of tumour recurrenceBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Serum CA 125 in epithelial ovarian cancer. A longitudinal studyBJOG: An International Journal of Obstetrics and Gynaecology, 1987
- Ultrasonography for early detection of ovarian carcinomaBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- REAL-TIME ULTRASONOGRAPHY FOR DETERMINATION OF OVARIAN MORPHOLOGY AND VOLUMEThe Lancet, 1982
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- MONITORING OVARIAN FOLLICULAR DEVELOPMENT WITH REAL‐TIME ULTRASOUNDBJOG: An International Journal of Obstetrics and Gynaecology, 1980